Multi-Modal Melanoma Detection System

• Multi-modal melanoma detection systems are techniques that merge heterogeneous data (WSIs, dermoscopic, smartphone images, and metadata) to enhance lesion classification and grading.
• They integrate specialized preprocessing, fusion strategies, and multi-agent frameworks to efficiently address diagnostic challenges using neural networks and explainability methods.
• Evaluations on benchmark datasets (e.g., M-Path, PH2) demonstrate improved accuracy, sensitivity, and interpretability, supporting early detection and human-AI collaboration.

A multi-modal melanoma detection system integrates heterogeneous data streams and algorithmic techniques to improve the identification, grading, and classification of melanocytic lesions. Such systems leverage image-based data (ranging from histopathological whole-slide images to dermoscopic and smartphone photographs) and text or metadata (e.g., patient demographics, clinical features, natural language descriptions) to enable robust diagnostics. Multi-modal models span a spectrum from mobile early-warning applications to advanced, multi-agent frameworks that emulate expert pathologist workflows. Emphasis is placed on the fusion of visual and non-visual modalities, adaptive inference pipelines, explainability, and clinically relevant evaluation criteria.

1. Overview of Modalities and Data Streams

Multi-modal melanoma detection systems operate on diverse input modalities:

• Histopathology WSIs: High-resolution, gigapixel tissue images routinely used for granular diagnostic grading (Ghezloo et al., 13 Feb 2025).
• Dermoscopy: Magnified (typically 20×) images captured with specialized attachments, supporting lesion segmentation and characterization (Abuzaghleh et al., 2015).
• Smartphone Photographs: Consumer-grade photographs offering accessibility but posing challenges related to variable quality and missing clinical context (Sydorskyi et al., 21 Jan 2026).
• Metadata: Structured tabular data such as age, sex, anatomical site, skin type, and derived features (e.g., lesion size ratios, color contrasts).
• Textual Summaries: Human or machine-generated natural language descriptions of histologic or photographic findings.

Preprocessing is tailored to each stream: background filtering for WSIs (discarding patches with saturation <15 (Ghezloo et al., 13 Feb 2025)), center-cropping and resizing for photo images (128×128 via INTER_LANCZOS4 (Sydorskyi et al., 21 Jan 2026)), and complex feature engineering (e.g., pigment network analysis, shape metrics (Abuzaghleh et al., 2015)). Metadata streams undergo imputation and one-hot encoding, with missingness explicitly modeled.

2. System Architectures and Integration Strategies

Design architectures are characterized by multi-branch neural networks, multi-stage processing, or explicit agent orchestration. Three representative frameworks illustrate the spectrum:

System	Modalities	Integration
PathFinder (Ghezloo et al., 13 Feb 2025)	WSI, text	Multi-agent, agent fusion
SKINcure (Abuzaghleh et al., 2015)	Dermoscopy, UV	Modular, server–mobile
Sydorskyi et al. (Sydorskyi et al., 21 Jan 2026)	Photo, tabular	Parallel fusion, pipeline

PathFinder uses four specialized agents (Triage, Navigation, Description, Diagnosis) operating on WSIs and textual patch summaries. Multi-modal embeddings are iteratively aggregated, with agent-to-agent conditioning via text encodings and spatial sampling guided by transformer and U-Net architectures.

SKINcure employs a dual-module structure: a UV-exposure alert and a dermoscopic analysis pipeline, integrating environmental factors and preprocessed images. Classification relies on cascaded SVMs with engineered feature vectors.

Sydorskyi et al. introduce dual-branch neural networks for parallel processing of images and metadata, culminating in a late-fusion MLP. Their approach incorporates a three-stage boosting pipeline and accommodates missing metadata via fallback inference modes.

3. Key Algorithms and Mathematical Formulations

Core algorithmic motifs include:

Patch-Based and Iterative Sampling (PathFinder)

• Triage: Quilt-Net-embedded patches $x_i$ processed via transformers and multi-scale convolution ($$L_\text{triage} = -[y\log \hat{y} + (1-y)\log(1-\hat{y})]$$).
• Navigation: At iteration $t$, importance maps $M^{(t)}$ are generated by a text-conditioned U-Net: $M^{(t)} = f_\text{Nav}(I^{(t)}, E(t-1))$; sample $$P^{(t)}(i,j) = M^{(t)}(i,j)/\sum_{i',j'} M^{(t)}(i',j')$$ for ROI localization.
• Text Fusion: Aggregated context $$E(t) = \frac{1}{t} \sum_{k=1}^{t} \text{T5}_\text{text}(D(k))$$.

Multi-Stage Classification (SKINcure)

• Image Analysis: Hair exclusion via morphological top-hat filtering and inpainting:

$$I_\text{gray}(x,y) = 0.299\,R + 0.587\,G + 0.114\,B$$

• Segmentation: Global thresholding (Otsu, active contours). Feature extraction encompasses FFT, DCT, color and pigment metrics.
• Cascaded SVMs: Stage I distinguishes “Normal” vs. “Abnormal”, Stage II classifies “Atypical” vs. “Melanoma”, using RBF kernels.

Multi-Modal Neural Fusion and Boosting (Sydorskyi et al.)

• Image Branch: $$f_\text{img}(x) = \text{MLP}_\text{img}(\text{GeM}(\phi(x)))$$
• Metadata Branch: $f_\text{meta}(m) = \text{MLP}_\text{meta}(m)$
• Late Fusion: $$\hat{y} = \sigma(W_f [f_\text{img}(x)\,\|\,f_\text{meta}(m)] + b_f)$$
• Pipeline: Three-stage model: (1) multi-modal NN, (2) boosting (XGBoost/LightGBM) on OOF predictions and metadata, (3) weighted ensembling via $\alpha_j \cdot \text{ranknorm}(p_i^{(j)})$, optimizing partial ROC AUC.

Class imbalance is addressed through balanced batch sampling, focal/asymmetric losses, and random undersampling of majority class.

4. Evaluation Datasets, Metrics, and Comparative Performance

Benchmark datasets range from institutionally curated histopathology slides to public dermoscopy/photo repositories:

• M-Path (PathFinder): 238 WSIs, 4 consensus classes; balanced train/val/test splits; evaluation on micro-averaged accuracy, F1-score (Ghezloo et al., 13 Feb 2025).
• PH2 (SKINcure): 200 dermoscopic images; stratified 10-fold validation; confusion matrices and per-class sensitivity (Abuzaghleh et al., 2015).
• Kaggle/ISIC Archive (Sydorskyi et al.): Mixes smartphone and dermoscopic images, with metadata; metrics focus on partial ROC AUC (top 0.2 FPR) and retrieval sensitivity (Sydorskyi et al., 21 Jan 2026).

Key results:

System	Dataset	Top Metric	Accuracy/AUC	Comments
PathFinder	M-Path	Accuracy, F1	$74\%\pm1.2\%$	+8 pp SOTA, +9 pp pathologist
SKINcure	PH2	Per-class accuracy	Normal 96.3%, Melanoma 97.5%	Server-based SVM
Sydorskyi et al.	Kaggle/ISIC	Partial ROC AUC, @15 sens.	$0.18068$ (val AUC), $0.78371$ (top-15 sens.)	Three-stage ensemble

A consistent observation is that multi-modal systems surpass their unimodal counterparts, especially in regimes requiring high-sensitivity discrimination.

5. Explainability and Human-in-the-Loop Assessment

Explainable AI (XAI) is intrinsic to the latest systems:

• PathFinder: Generates natural language descriptions per ROI (e.g., “Spindle cells with hyperchromatic, oval nuclei and mild pagetoid spread”), enabling pathologists to audit predictions and rationales. Double-blind expert surveys report parity between PathFinder and GPT-4o in natural language description quality, with correctness as the principal criterion (~80% of choices) (Ghezloo et al., 13 Feb 2025).
• SKINcure and Sydorskyi et al.: Offer traceability through feature attributions (e.g., pigment network, color moments) and tabular metadata, although without explicit patch-level natural language.

A plausible implication is that the text-generative approach to patch-level annotation increases transparency and supports human-AI collaborative workflows.

6. Practical Deployment, Limitations, and Future Directions

Tradeoffs in deployment settings include:

• Server vs. Edge: SKINcure offloads computation to server, introducing latency and dependence on internet; future work targets on-device CNN acceleration (Abuzaghleh et al., 2015).
• Hardware Requirements: PathFinder’s transformer/U-Net backbone is compute-intensive, potentially limiting deployment outside research centers (Ghezloo et al., 13 Feb 2025).
• Data Generalization: Models trained on specific datasets (e.g., PH2, M-Path) show limited generalization without domain adaptation.
• Metadata Availability: Sydorskyi et al. address missing data by fallback to vision-only inference, maintaining robustness (Sydorskyi et al., 21 Jan 2026).

Proposed future directions include expansion to other cancer types and tissue sites, multi-center and federated learning for dataset diversity, embedding human-in-the-loop review interfaces, and scaling LLM-based diagnosis agents.

7. Clinical and Societal Implications

Multi-modal melanoma detection systems are reshaping triage and diagnostic workflows:

• Access: Deployment on consumer devices (photo upload, smartphone, teledermatology) can broaden screening reach, especially in resource-limited environments where dermoscopy or expert pathology is less available (Sydorskyi et al., 21 Jan 2026).
• Sensitivity-centric Metrics: Emphasizing partial ROC-AUC and top-k sensitivity directly optimizes for early, high-recall detection, a clinical imperative.
• Explainability: Machine-generated patch descriptions and feature visualizations can support auditability, regulatory compliance, and trust.

Limitations persist regarding clinical risks (e.g., missed “risky” WSIs due to triage agent false negatives in PathFinder), label noise, and variable imaging protocols.

---

References: PathFinder multi-agent WSI system (Ghezloo et al., 13 Feb 2025); SKINcure mobile dermoscopy and UV system (Abuzaghleh et al., 2015); Multi-modal photo+metadata CNN+boosting pipeline (Sydorskyi et al., 21 Jan 2026).